cromakalim has been researched along with kr 30450 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chae, SW; Cho, KP; Kang, HS; Kim, D; Kim, JS; Kwak, YG; Park, SK; Yoo, SE | 1 |
| Cho, TS; Jung, YS; Moon, CH; Shin, HS; Yoo, SE | 1 |
| Lee, BH; Seo, HW; Shin, HS; Yoo, SE | 1 |
| Hong, KW; Kim, CD; Shin, HS; Shin, YW; Yoo, Se | 1 |
| Lee, BH; Oh, JH; Seo, HW; Shin, HS | 1 |
| Kwan, YW; Lau, WM; To, KW; Tsang, SH | 1 |
6 other study(ies) available for cromakalim and kr 30450
| Article | Year |
|---|---|
KR-30450, a newly synthesized benzopyran derivative, activates the cardiac ATP-sensitive K+ channel.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cells, Cultured; Cromakalim; Glyburide; Guanidines; Heart; Phenylbutyrates; Potassium Channels; Pyrroles; Pyrrolidinones; Rats | 1995 |
Cardioprotective effects of KR-30450, a novel K+(ATP) opener, and its major metabolite KR-30818 on isolated rat hearts.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Heart; Heart Rate; Hypoglycemic Agents; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channel Blockers; Potassium Channels; Pyrimidines; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasodilator Agents | 1998 |
Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Benzopyrans; Coronary Circulation; Cromakalim; Dogs; Dose-Response Relationship, Drug; Hemodynamics; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium Channels; Pyrroles; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Vasodilation; Vasodilator Agents | 1998 |
Pharmacological profiles of SKP-450 and its family, a K+ channel opener, in comparison with levcromakalim.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Cromakalim; Dogs; Dose-Response Relationship, Drug; In Vitro Techniques; Potassium Channels; Pyrrolidinones; Rabbits; Rats; Rats, Inbred SHR; Stereoisomerism; Vasodilation; Vasodilator Agents | 1998 |
Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Blood Pressure; Cromakalim; Desoxycorticosterone; Heart Rate; Hypertension; Hypertension, Renal; Male; Potassium Channels; Pyrroles; Pyrrolidinones; Rats; Rats, Inbred SHR; Vasodilator Agents | 1998 |
Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
Topics: Adenosine Triphosphate; Aminoquinolines; Animals; Aorta, Thoracic; Apamin; Benzopyrans; Charybdotoxin; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Hypertension; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nicorandil; Nitroprusside; Norepinephrine; Picolines; Pinacidil; Potassium; Potassium Channels; Pulmonary Artery; Pyrans; Pyrrolidinones; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasodilator Agents | 1999 |